QL
AMLX icon

Quarry LP’s Amylyx Pharmaceuticals AMLX Stock Holding History

Quarry LP’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5K Buy
+139
New +$2.15K ﹤0.01% 1495
2024
Q2 		– Sell
-3,000
Closed -$8.52K – 1779
2024
Q1 		$8.52K Buy
3,000
+2,250
+300% +$29.4K ﹤0.01% 1228
2023
Q4 		$11K Sell
750
-4,250
-85% -$65.1K ﹤0.01% 1036
2023
Q3 		$91.5K Buy
+5,000
New +$106K 0.02% 212

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Quarry LP's AMLX Position: Q2 2026 in Review

Quarry LP opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 139 shares worth $2.5K. The stake represents ﹤0.01% of the portfolio and ranks #1495 among its holdings. This is a return to the name: Quarry LP previously reported a position in AMLX as recently as Q1 2024.

Quarry LP first reported a position in AMLX in Q3 2023 and has held it in 4 quarters since. The position peaked at $91.5K in Q3 2023. 207 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Quarry LP held 139 shares of Amylyx Pharmaceuticals worth $2.5K as of Q2 2026.
  • Amylyx Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1495 holding.
  • Quarry LP first reported a position in Amylyx Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • Quarry LP's Amylyx Pharmaceuticals position peaked at $91.5K in Q3 2023.
  • 207 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.